WuXi Biologics receives international honor

A view of WuXi Biologics, a global open-access biologics technology platform company in Binhu district, Wuxi city. [Photo/IC]

WuXi Biologics, a global biologics service provider in Binhu district, Wuxi, won the 2018 Asia-Pacific Bioprocessing Excellence Awards from IMAPAC, a leading consulting firm.

The award recognizes leading biopharmaceutical enterprises for their contributions to reducing costs and developing advanced technologies for the world to use.

WuXi Biologics is home to industry-leading bioprocessing experts and has brought about rapid advances in technology and manufacturing. It offers end-to-end solutions in the realms of biologics discovery, development and manufacturing.

"With significant investment in the research and development of innovative technologies, our company has built an international platform covering China, Ireland, Singapore and the United States," said Dr. Chen Zhisheng, CEO of WuXi Biologics, "and we hope to launch more biopharmaceuticals which are urgently needed in clinical treatment around the world as soon as possible."